Clearmind Medicine Inc. financial data

Symbol
CMND on Nasdaq
Location
Vancouver, British Columbia, Canada (Federal Level)
Fiscal year end
31 October
Latest financial report
20-F - Q3 2025 - 20 Jan 2026

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 158,076 shares

Income Statement

Label TTM Value / Value Unit Change %
Research And Development Expense $2,056,525 USD 49%
General And Administrative Expense $3,610,652 USD -17%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets $6,083,052 USD -16%
Liabilities $4,890,456 USD 18%